Literature DB >> 19910492

Anti-integrin monoclonal antibodies.

Adam Byron1, Jonathan D Humphries, Janet A Askari, Sue E Craig, A Paul Mould, Martin J Humphries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19910492      PMCID： PMC3329622          DOI： 10.1242/jcs.056770

Source DB:  PubMed          Journal:  J Cell Sci        ISSN： 0021-9533            Impact factor:   5.285


× No keyword cloud information.
  12 in total

1.  Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.

Authors:  Jian-Ping Xiong; Thilo Stehle; Rongguang Zhang; Andrzej Joachimiak; Matthias Frech; Simon L Goodman; M Amin Arnaout
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

3.  Does the integrin alphaA domain act as a ligand for its betaA domain?

Authors:  José Luis Alonso; Makram Essafi; Jian Ping Xiong; Thilo Stehle; M Amin Arnaout
Journal:  Curr Biol       Date:  2002-05-14       Impact factor: 10.834

Review 4.  Integrin structure.

Authors:  M J Humphries
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

Review 5.  Integrin structure, allostery, and bidirectional signaling.

Authors:  M A Arnaout; B Mahalingam; J-P Xiong
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

6.  Structural basis of integrin activation by talin.

Authors:  Kate L Wegener; Anthony W Partridge; Jaewon Han; Andrew R Pickford; Robert C Liddington; Mark H Ginsberg; Iain D Campbell
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

Review 7.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

8.  The inhibitory anti-beta1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function.

Authors:  A P Mould; S K Akiyama; M J Humphries
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

Review 9.  The identification and optimization of orally efficacious, small molecule VLA-4 antagonists.

Authors:  Donna M Huryn; Andrei W Konradi; Susan Ashwell; Stephen B Freedman; Louis J Lombardo; Michael A Pleiss; Eugene D Thorsett; Ted Yednock; Jeffrey D Kennedy
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

10.  Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration.

Authors:  Melissa R Andrews; Stefan Czvitkovich; Elisa Dassie; Christina F Vogelaar; Andreas Faissner; Bas Blits; Fred H Gage; Charles ffrench-Constant; James W Fawcett
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167
View more
  90 in total

1.  Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking.

Authors:  Shweta Tiwari; Janet A Askari; Martin J Humphries; Neil J Bulleid
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

2.  Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2.

Authors:  Xing Chen; Can Xie; Noritaka Nishida; Zongli Li; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Modulus-driven differentiation of marrow stromal cells in 3D scaffolds that is independent of myosin-based cytoskeletal tension.

Authors:  Sapun H Parekh; Kaushik Chatterjee; Sheng Lin-Gibson; Nicole M Moore; Marcus T Cicerone; Marian F Young; Carl G Simon
Journal:  Biomaterials       Date:  2010-12-21       Impact factor: 12.479

4.  Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection.

Authors:  Jay Vornhagen; Blair Armistead; Verónica Santana-Ufret; Claire Gendrin; Sean Merillat; Michelle Coleman; Phoenicia Quach; Erica Boldenow; Varchita Alishetti; Christina Leonhard-Melief; Lisa Y Ngo; Christopher Whidbey; Kelly S Doran; Chad Curtis; Kristina M Adams Waldorf; Elizabeth Nance; Lakshmi Rajagopal
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 5.  Reconstruction of integrin activation.

Authors:  Feng Ye; Chungho Kim; Mark H Ginsberg
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

6.  Blocking integrin inactivation as an anti-angiogenic therapy.

Authors:  Pipsa Saharinen; Johanna Ivaska
Journal:  EMBO J       Date:  2015-03-31       Impact factor: 11.598

7.  Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.

Authors:  Manuel Valiente; Karuna Ganesh; Ekrem Emrah Er; Yilong Zou; Saloni Agrawal; Jing Hu; Bailey Griscom; Marc Rosenblum; Adrienne Boire; Edi Brogi; Filippo G Giancotti; Melitta Schachner; Srinivas Malladi; Joan Massagué
Journal:  Nat Cell Biol       Date:  2018-07-23       Impact factor: 28.824

8.  Heterotropic modulation of selectin affinity by allosteric antibodies affects leukocyte rolling.

Authors:  Sebastian B Riese; Christian Kuehne; Thomas F Tedder; Rupert Hallmann; Erhard Hohenester; Konrad Buscher
Journal:  J Immunol       Date:  2014-01-15       Impact factor: 5.422

Review 9.  Modulating the stem cell niche for tissue regeneration.

Authors:  Steven W Lane; David A Williams; Fiona M Watt
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 10.  Periostin and TGF-β-induced protein: Two peas in a pod?

Authors:  Deane F Mosher; Mats W Johansson; Mary E Gillis; Douglas S Annis
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-08-10       Impact factor: 8.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.